WO2010000207A1 - 一种天然蒜素片及其制备方法 - Google Patents
一种天然蒜素片及其制备方法 Download PDFInfo
- Publication number
- WO2010000207A1 WO2010000207A1 PCT/CN2009/072602 CN2009072602W WO2010000207A1 WO 2010000207 A1 WO2010000207 A1 WO 2010000207A1 CN 2009072602 W CN2009072602 W CN 2009072602W WO 2010000207 A1 WO2010000207 A1 WO 2010000207A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- allicin
- weight
- parts
- content
- natural
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/105—Persulfides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Definitions
- the present invention relates to a plant extract preparation, in particular to a quick-acting antibacterial, anti-viral, ultra-concentrated natural allicin tablet and a preparation method thereof.
- allicin tablets with a tablet weight of 600 mg/tablet, allicin content of 20 mg/tablet, 2 to 3 times per day for adults, and 4 to 6 tablets per oral dose for reasonable doses; there are also other pharmaceutical companies.
- the content of allicin is 25mg/tablet (not natural, synthetic), 2 ⁇ 3 times a day, 2 tablets per oral dose is a reasonable dose, and it is considered that exceeding this amount has adverse effects on the human body.
- the problem to be solved by the present invention is to overcome the deficiencies of the prior art, and provide a quick-acting antibacterial anti-inflammatory and anti-virus which can be adapted to the weight of a unit human body, has a particularly high content of monolithic heavy allicin, and has good taking effect. Super concentrated natural allicin tablets.
- Natural allicin powder with a content of 21 ⁇ 90% allicin (produced and sold by Hangzhou Shenzhou Institute of Earth Ecology and Culture) is the main raw material, and is made into other tablets with other nutrients (all commercially available). Good curative effect.
- the quick-acting antibacterial, anti-viral and anti-viral natural allicin tablets of the invention are uniformly compressed by the raw materials, and are divided into two types from the tableting preparation:
- a product without starch and garlic powder, the content of allicin can reach 200mg ⁇ 800mg/g tablet weight
- the release agent is mainly used for tableting, which facilitates easy release of the lower, middle and upper molds of the machine, and does not stick to the mold. It has nothing to do with the content of allicin.
- the release agent is preferably magnesium stearate.
- immunoglobulin Y in an amount of 50 to 95% or immunoglobulin G20 to 40 parts by weight in an amount of 50 to 95%
- spinach leeks, grass head, beet, malan head, eggplant, day lily, mushroom, cucumber, watermelon, melon, banana, rapeseed, alfalfa, alfalfa, lotus seed, lotus seed, green tea, chrysanthemum, honeysuckle, apple, pear
- the cool food supplement is preferably a green bean sprout and a lily extract, and the extract content is 40 to 95% (the Crop Science Research Institute of the Chinese Academy of Agricultural Sciences, the Hangzhou Shenzhou Earth Ecology and Culture Research Institute, etc.) are produced and sold. If there is no cold food supplement in the natural allicin tablets, the hot body can also supplement the cold food in the period of taking the natural allicin tablets.
- the latter method for preparing allicin tablets is that starch and garlic powder are firstly mixed with natural allicin powder, and then with natural sesamin, immunoglobulin-y or immunoglobulin-G, magnesium stearate ( Or add cold food supplements. Stir well and compress, which is better.
- the allicin content of the aforementioned natural allicin powder raw material is preferably 65 to 75%.
- Allicin tablets specifications lOOOOmg / tablets (lg / tablet), each piece of garlic content of 200 ⁇ 800mg.
- Dosage According to the weight of the individual, 1 tablet / 10kg each time, 2 to 3 times a day.
- the natural allicin tablet of the invention has the characteristics of particularly high content of allicin per single tablet, and proves in practical application that: a large dose of natural allicin must be taken in the relief of a severely ill patient, and the human body is basically taken every time.
- the body weight is 200 to 700 mg per 10 kg. That is to say: a person, if the weight is 100 kg or 50 kg, he ( ⁇ she) every time the oral dose of natural allicin should be 1000 ⁇ 3500mg / time, 2 ⁇ 3 times a day. Only in this way can we quickly and effectively kill inflammation, viruses and harmful bacteria in the body, without any side effects, nor Resistant to chemicals, very safe and peaceful.
- the allicin tablet of the invention is the highest content of allicin in the allicin tablets which have been sold in the domestic and foreign markets, and the most safe dosage of the allicin tablets, which can quickly and effectively alleviate or cure inflammation and harmful bacteria and Symptoms of viral disease without any side effects.
- Figure 1 is a map of the efficacy components of a batch of natural allicin powder.
- Test item name Unit Standard value Measured value Unit judgment Net content negative deviation 0/
- the weight of the natural allicin tablets of the present invention can be determined as needed, such as 0.5 g, 1.5 g.
- Etc. the following example uses lg / piece.
- Example 2 [95] 500g of natural allicin powder with anisein content of 65 ⁇ 70% and 230g of starch, plus 230g of garlic powder mixed and stirred evenly, and then put 20g of natural sesamin with a sesamin content of 65%, the content is 80 % of immunoglobulin-G20g, 2g of magnesium stearate (total weight of the raw material is 1002g), stir evenly, compress 1002 pieces, the weight of each piece of garlic is >300113 ⁇ 4, up to 324mg ⁇ 350mg.
- the amount of allicin in each tablet can reach 218113 ⁇ 4 ⁇ 235113 ⁇ 4.
Description
Claims
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL09771977T PL2347757T3 (pl) | 2008-07-03 | 2009-07-02 | Naturalna tabletka allicynowa i sposób jej przygotowania |
EP09771977A EP2347757B1 (en) | 2008-07-03 | 2009-07-02 | A natural allicin tablet and preparation method thereof |
ES09771977T ES2400597T3 (es) | 2008-07-03 | 2009-07-02 | Un comprimido de alicina natural y método de preparación del mismo |
JP2011515076A JP5709744B2 (ja) | 2008-07-03 | 2009-07-02 | 天然アリシン(Allicin)錠剤及びその調製方法 |
CA2729617A CA2729617C (en) | 2008-07-03 | 2009-07-02 | A natural allicin tablet and preparation method thereof |
DK09771977.7T DK2347757T3 (da) | 2008-07-03 | 2009-07-02 | Naturlig allicintablet og fremgangsmåde til fremstilling heraf |
AU2009266205A AU2009266205B2 (en) | 2008-07-03 | 2009-07-02 | A natural allicin tablet and preparation method thereof |
US12/943,034 US8216617B2 (en) | 2008-07-03 | 2010-11-10 | Tablet comprising natural allicin and method for producing the same |
US13/107,947 US20110212082A1 (en) | 2008-07-03 | 2011-05-15 | Method for producing tablet comprising natural allicin |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810062759.7 | 2008-07-03 | ||
CN200810062759A CN101342148B (zh) | 2008-07-03 | 2008-07-03 | 一种速效抗菌消炎、抗病毒的超浓缩天然蒜素片及其制备方法 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/943,034 Continuation US8216617B2 (en) | 2008-07-03 | 2010-11-10 | Tablet comprising natural allicin and method for producing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010000207A1 true WO2010000207A1 (zh) | 2010-01-07 |
Family
ID=40244342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2009/072602 WO2010000207A1 (zh) | 2008-07-03 | 2009-07-02 | 一种天然蒜素片及其制备方法 |
Country Status (10)
Country | Link |
---|---|
US (2) | US8216617B2 (zh) |
EP (1) | EP2347757B1 (zh) |
JP (1) | JP5709744B2 (zh) |
CN (2) | CN101342148B (zh) |
AU (1) | AU2009266205B2 (zh) |
CA (1) | CA2729617C (zh) |
DK (1) | DK2347757T3 (zh) |
ES (1) | ES2400597T3 (zh) |
PL (1) | PL2347757T3 (zh) |
WO (1) | WO2010000207A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112552387A (zh) * | 2020-12-31 | 2021-03-26 | 山西大学 | 一种黄花菜抗肿瘤活性蛋白及其制备方法和应用 |
CN115887451A (zh) * | 2023-01-05 | 2023-04-04 | 山东国邦药业有限公司 | 一种盐酸左旋咪唑片及其制备方法 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017032711A1 (en) * | 2015-08-21 | 2017-03-02 | Gratia Mundi Gmbh | Active combinations, compositions and methods for enhancing hair growth |
CN107296799A (zh) * | 2017-07-05 | 2017-10-27 | 北京罗麦科技有限公司 | 一种蒜素片及其制备方法 |
JP7198630B2 (ja) | 2018-10-26 | 2023-01-04 | 小林製薬株式会社 | 経口組成物 |
WO2020241814A1 (ja) * | 2019-05-29 | 2020-12-03 | 国立大学法人東京大学 | 抗ウイルス剤又はウイルスcccDNA形成阻害剤 |
WO2023128999A1 (en) * | 2021-12-28 | 2023-07-06 | Istanbul Medipol Universitesi Teknoloji Transfer Ofisi Anonim Sirketi | Natural compounds with anti-inflammatory effect |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1448129A (zh) * | 2003-04-24 | 2003-10-15 | 中国人民解放军沈阳军区总医院 | 大蒜素和大蒜油环糊精衍生物包合物及其制备方法 |
CN1666765A (zh) * | 2004-03-10 | 2005-09-14 | 徐华 | 提高人体免疫功能预防病毒的天然抗氧化剂 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58157722A (ja) * | 1982-03-13 | 1983-09-19 | Green Cross Corp:The | 炎症治療予防剤 |
JPH06227977A (ja) * | 1993-02-01 | 1994-08-16 | Suntory Ltd | 活性酸素消去剤 |
WO1995022971A1 (en) * | 1994-02-25 | 1995-08-31 | New England Deaconess Hospital Corporation | Anti-inflammatory and infection protective effects of sesamin-based lignans |
US20080275110A1 (en) * | 2004-12-28 | 2008-11-06 | Yoshiko Ono | Sesamin/Episesamin Compositions |
WO2008007728A1 (fr) * | 2006-07-13 | 2008-01-17 | Kaneka Corporation | Préparation orale contenue dans une structure à membrane lipidique, et agent contre la fatigue comprenant une coenzyme comme ingrédient actif |
JP2008105998A (ja) * | 2006-10-25 | 2008-05-08 | Tm East:Kk | Msm、ガーリック及びafaの混合粉末からなる健康食品 |
JP2008273874A (ja) * | 2007-04-27 | 2008-11-13 | Fuji Chem Ind Co Ltd | 頭皮外用剤 |
-
2008
- 2008-07-03 CN CN200810062759A patent/CN101342148B/zh active Active
-
2009
- 2009-07-02 PL PL09771977T patent/PL2347757T3/pl unknown
- 2009-07-02 AU AU2009266205A patent/AU2009266205B2/en not_active Ceased
- 2009-07-02 CA CA2729617A patent/CA2729617C/en active Active
- 2009-07-02 JP JP2011515076A patent/JP5709744B2/ja active Active
- 2009-07-02 DK DK09771977.7T patent/DK2347757T3/da active
- 2009-07-02 CN CN200910303931A patent/CN101683326A/zh active Pending
- 2009-07-02 EP EP09771977A patent/EP2347757B1/en active Active
- 2009-07-02 ES ES09771977T patent/ES2400597T3/es active Active
- 2009-07-02 WO PCT/CN2009/072602 patent/WO2010000207A1/zh active Application Filing
-
2010
- 2010-11-10 US US12/943,034 patent/US8216617B2/en active Active
-
2011
- 2011-05-15 US US13/107,947 patent/US20110212082A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1448129A (zh) * | 2003-04-24 | 2003-10-15 | 中国人民解放军沈阳军区总医院 | 大蒜素和大蒜油环糊精衍生物包合物及其制备方法 |
CN1666765A (zh) * | 2004-03-10 | 2005-09-14 | 徐华 | 提高人体免疫功能预防病毒的天然抗氧化剂 |
Non-Patent Citations (2)
Title |
---|
LI HONG-ZHONG ET AL.: "the effect of allicin on adjuvant arthritis rats", CHINESE PHARMACOLOGICAL BULLETIN, vol. 23, no. 07, July 2007 (2007-07-01), pages 902 - 906, XP008141217 * |
See also references of EP2347757A4 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112552387A (zh) * | 2020-12-31 | 2021-03-26 | 山西大学 | 一种黄花菜抗肿瘤活性蛋白及其制备方法和应用 |
CN112552387B (zh) * | 2020-12-31 | 2022-11-11 | 山西大学 | 一种黄花菜抗肿瘤活性蛋白及其制备方法和应用 |
CN115887451A (zh) * | 2023-01-05 | 2023-04-04 | 山东国邦药业有限公司 | 一种盐酸左旋咪唑片及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CA2729617C (en) | 2018-02-27 |
CN101342148A (zh) | 2009-01-14 |
EP2347757B1 (en) | 2012-11-28 |
CA2729617A1 (en) | 2010-01-07 |
CN101342148B (zh) | 2012-09-05 |
EP2347757A4 (en) | 2012-05-09 |
AU2009266205A1 (en) | 2010-01-07 |
AU2009266205B2 (en) | 2013-12-19 |
EP2347757A1 (en) | 2011-07-27 |
JP5709744B2 (ja) | 2015-04-30 |
DK2347757T3 (da) | 2013-03-18 |
CN101683326A (zh) | 2010-03-31 |
PL2347757T3 (pl) | 2013-06-28 |
JP2011526255A (ja) | 2011-10-06 |
ES2400597T3 (es) | 2013-04-11 |
US20110212082A1 (en) | 2011-09-01 |
US20110052568A1 (en) | 2011-03-03 |
US8216617B2 (en) | 2012-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102698123B (zh) | 治疗猪传染性胃肠炎的中药组合物、饲料、制备和应用 | |
WO2010000207A1 (zh) | 一种天然蒜素片及其制备方法 | |
CN101953985A (zh) | 一种具有清肺止咳作用的药物 | |
CN102657794A (zh) | 用于预防和治疗鸡白痢的中药、制备方法和饲料 | |
CN103157095B (zh) | 芸豆植物凝集素在制备人用药物中的应用及其药物组合物 | |
CN109288889A (zh) | 一种抗菌妇科组合物、凝胶及其制备方法 | |
CN103721103B (zh) | 用于治疗猪丹毒的药物及其制备方法 | |
CN111265599A (zh) | 番茄红素和葡萄籽组合物在制备治疗关节炎药物中的应用 | |
CN103494927A (zh) | 一种用于治疗鸡呼吸道疾病的中药组合物及其制备方法 | |
CN106511675A (zh) | 一种用于防治家禽疾病的药及其制备方法 | |
CN113577187B (zh) | 一种治疗流行性感冒的中药组合物、中药提取物及其制备方法和应用 | |
CN108245531B (zh) | 一种改善胃肠道功能、防治便秘的组合物 | |
CN105560444B (zh) | 一种用于治疗牦牛胃肠炎的藏药组合物及其制备方法和应用 | |
CN109432287B (zh) | 一种防治家禽气分热盛证的中药口服液及其制备方法 | |
CN103520316A (zh) | 一种防治畜禽腹泻的中药及其制备方法 | |
CN103520267A (zh) | 一种可湿性止痢散及其制备方法 | |
CN1698691A (zh) | 一种治疗肺热(毒)咳嗽的药物及其制备方法 | |
CN105878875A (zh) | 一种用于防治禽坏死性肠炎的中药超微粉颗粒剂及其制备方法 | |
CN108785383A (zh) | 一种抗菌妇科外用药物组合物及其制备方法与应用 | |
CN103463401B (zh) | 小儿用哮喘药 | |
CN112618600B (zh) | 一种用于治疗犊牛胃肠道疾病药物的藏药复方及其制备方法 | |
CN102671133B (zh) | 用于治疗猪霉形体性肺炎的中药和制备方法 | |
CN107320547B (zh) | 一种治疗食管癌的药物及其制备方法 | |
CN106562090A (zh) | 一种成年鸡用饲料 | |
CN111956777A (zh) | 一种快速退热的中药及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09771977 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2729617 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009771977 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2011515076 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 52/MUMNP/2011 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009266205 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2009266205 Country of ref document: AU Date of ref document: 20090702 Kind code of ref document: A |